ClinConnect ClinConnect Logo
Search / Trial NCT06876883

MItral Regurgitation Risk Assessment and CLinical ModElling

Launched by SUN YAT-SEN UNIVERSITY · Mar 13, 2025

Trial Information

Current as of April 29, 2025

Recruiting

Keywords

Mitral Regurgitation All Cause Mortality Clinical Modelling Cardiovascular Mortality Heart Failure Hospitalization

ClinConnect Summary

The MItral Regurgitation Risk Assessment and CLinical ModElling (MIRACLE) study is looking into mitral regurgitation (MR), which is a heart condition where the heart's mitral valve doesn't close properly, leading to blood leaking backward into the heart. This condition can lead to serious issues like heart failure if not treated. The trial aims to identify important risk factors that affect patients with moderate to severe MR, helping doctors make better decisions about patient care.

To participate in this study, you need to be an adult over 18 years old who has been diagnosed with at least moderate MR during a hospital stay. Unfortunately, if someone is unable to give written consent for their participation, they won't be able to join. If you or a loved one qualifies, you can expect to be part of a research effort that may improve future treatment for this heart condition. The study is currently recruiting participants, and everyone's involvement could contribute to important findings in heart health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients diagnosed with ≥ moderate mitral regurgitation during hospitalization.
  • Aged over 18 yrs.
  • Exclusion Criteria:
  • Patients unable to provide written consent.

About Sun Yat Sen University

Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported